While the use of deep learning in drug discovery is gaining increasing attention, the lack of methods to computate reliable errors in prediction for Neural Networks prevents their application to guide decision making in domains where identifying unreliable predictions is essential, e.g. precision medicine. Here, we present a framework to compute reliable errors in prediction for Neural Networks using Test-Time Dropout and Conformal Prediction. Specifically, the algorithm consists of training a single Neural Network using dropout, and then applying it N times to both the validation and test sets, also employing dropout in this step. Therefore, for each instance in the validation and test sets an ensemble of predictions were generated. The residuals and absolute errors in prediction for the validation set were then used to compute prediction errors for test set instances using Conformal Prediction. We show using 24 bioactivity data sets from ChEMBL 23 that dropout Conformal Predictors are valid (i.e., the fraction of instances whose true value lies within the predicted interval strongly correlates with the confidence level) and efficient, as the predicted confidence intervals span a narrower set of values than those computed with Conformal Predictors generated using Random Forest (RF) models. Lastly, we show in retrospective virtual screening experiments that dropout and RF-based Conformal Predictors lead to comparable retrieval rates of active compounds. Overall, we propose a computationally efficient framework (as only N extra forward passes are required in addition to training a single network) to harness Test-Time Dropout and the Conformal Prediction framework, and to thereby generate reliable prediction errors for deep Neural Networks.
Introduction
The application of deep learning in preclinical and clinical applications is gaining increasing attention [1] [2] [3] [4] . While alternative algorithms used in computer-aided drug design are still widely used, such as Random Forest (RF) or Support Vector Machines, the versatility of deep learning in terms of the diversity of architectures or feature representations that can be used as input (e.g., from compound fingerprints to images of compounds 5, 6 , cells 7 , or whole-slide pathology images 8, 9 ) renders it a suitable modelling strategy in diverse drug discovery applications [10] [11] [12] [13] .
However, the difficulty in interpreting how deep learning models work in most cases and the lack of methods to generate well-calibrated errors in prediction makes it challenging to apply Deep Neural Networks (DNN) to guide decision making in applications were knowing the reliability of individual predictions is essential e.g., personalized medicine 14, 15 .
The development of techniques for the estimation of the reliability of individual predictions is a major research area in machine learning, and it is of particular importance in the area of drug discovery, where both the predicted property and the associated uncertainty of this prediction needs to be considered for decision making 16 . A plethora of algorithmic approaches have been proposed to this end, including metrics based on the distance of test instances to those in the training set 17, 18 , uncertainty estimation using Bayesian inference [19] [20] [21] [22] [23] [24] , and methods based on the bagged variance across base learners in model ensembles 25, 26 , among others [27] [28] [29] . In the context of deep learning, harnessing Test-Time Dropout predictions to model predictions uncertainty has gained increasing attention over the last years 23, 30 . The main idea consists of training a Neural Network using dropout. Once trained, the network is applied on the test set to compute N forward passes using dropout as well. The variability across forward passes can be used to compute errors in prediction using Bayesian variational inference 23, 30 . In addition to these Bayesian approaches 23, 30 , we recently showed that Snapshot Ensembles and Conformal
Prediction can be integrated to generate reliable confidence intervals for deep learning architectures 31 . However, the development of algorithms to model predictions uncertainty using deep learning and Conformal Prediction in the context of regression still remains vastly unexplored 31 .
The application of Conformal Prediction in drug discovery is becoming widely used [32] [33] [34] [35] because: (i) the predicted confidence intervals are easy to interpret (e.g., at a confidence level of 90%, at least 90% of the predicted confidence regions will contain the true value) 29 ; (ii) the sound mathematical framework on which Conformal Prediction is based 36, 37 guarantees that the confidence intervals are always valid (i.e., the fraction of instances for which the true value lies within the predicted region will not be smaller than the chosen confidence level) provided that the exchangeability principle is fulfilled, which is generally assumed when modelling preclinical data 29, 36, 37 , although this is not always the case 38 ; (iii) each prediction consists of a confidence region in the case of regression, whose size depends on the user-defined Confidence Level (CL), and well-calibrated class probabilities in the case of classification 37 ; (iv) Conformal
Prediction can be used in combination with any machine learning algorithm and requires minimal computational cost beyond the training of the underlying algorithm 29 ; (v) no parameterization is needed beyond the selection of a non-conformity function 39 . Hence, Conformal Prediction can be used in drug discovery to compute reliable errors in prediction at minimal computational cost.
In the current work, we explore the possibility of utilizing 
Methods

Data Sets
In this study we used 24 IC50 data sets extracted from ChEMBL version 23 40 , which have been previously modelled in several studies 31, 38 . Briefly, we downloaded IC50 data for 24 diverse protein targets from ChEMBL using the chembl_webresource_client python module [41] [42] [43] . Only IC50 values for molecules that satisfied the following filtering criteria were considered: (i) activity relationship equal to '=', (ii) an activity unit equal to "nM", (iii) target type equal to "SINGLE PROTEIN", and (iv) organism equal to Homo sapiens. IC50 values were modeled in a logarithmic scale (pIC50 = −log10 IC50). The average pIC50 value was calculated when multiple pIC50 values were available for the same compound. Further information about the data sets is given in Table 1 and 31, 38 . The data sets are available in the Supporting Information of a previous study 38 . 
Molecular Representation
All chemical structures were standardized to a common representation scheme using the python module standardizer (https://github.com/flatkinson/standardiser). Inorganic molecules were removed. The largest fragment was kept in order to filter out counterions, following standard procedures in the field 44, 45 . Circular Morgan fingerprints 46 were computed using RDkit (release version 2013.03.02) 47 . The radius was set to 2 and the fingerprint length to 2,048.
Machine Learning -Data Splitting
The data sets were randomly split into a training set (70% of the data), a validation set (15%), and a test set (15%). For each data set, the training set was used to train a given network, whereas the validation set served to monitor the performance of the network during the training phase. In case of RF models, both the training and validation sets were used for model training.
The predictive power of the final RF and DNN model was evaluated on the test set. The above split (and associated model training and testing) was repeated 20 times with random data set assignments.
-Deep Neural Networks (DNN)
DNNs were trained using the python library Pytorch 48 . We defined four hidden layers, composed of 1000, 1000, 100 and 10 nodes, respectively. The number of neurons in each layer was selected to be smaller than the input fingerprint size to reduce the chances of overfitting 49 .
Rectified linear unit (ReLU) activation was used in all cases. The training data was processed in batches of size equal to 15% of the number of instances. We used Stochastic Gradient Descent with Nesterov momentum, which was set to 0.9 and kept constant during the training phase 50 .
The networks were trained over 4,000 epochs, and early stopping was used in all cases, i.e., the training of a given network was stopped if the validation loss did not decrease after 300
epochs. Cyclical learning rate annealing was implemented to train all networks 51, 52 . Specifically, the learning rate was initially set to 0.005, and was decreased by 40% every 200 epochs. The learning rate was set back to the initial value (i.e., 0.005) after 1,000 epochs and the annealing process repeated in the same way as done for the first 1,000 epochs. Setting back the learning rate to a high value permits to escape local minima by sampling larger regions of the loss landscape 51, 52 . We used either 10%, 20% or 50% dropout in the four hidden layers both during training and at test time 2, 53, 54 . The RMSE on the validation set was used as the loss function during the training of all networks. DNNs that failed to converge to RMSE values on the validation set smaller than 1.2 pIC50 units were discarded.
-Random Forests (RF)
RF models were trained using the python library scikit-learn 55 as previously described 31, 38 .
Briefly, the default parameter values were used except for the number of trees, which was set to 100, as using a larger number of trees does not result in increased generalization capability and this value has been found to be a suitable choice in previous chemical structure-activity modelling studies 56, 57 .
Conformal Prediction -Dropout Conformal Prediction
We describe below the steps followed to generate Conformal Predictors using Test-Time Dropout ( Figure 1 ). We refer the reader to the work of Vovk et al. 29, 36, 37 for further theoretical details about the Conformal Prediction framework.
Firstly, a Neural Network was trained on the training and validation sets using dropout regularization 53 (step 1). Subsequently, it was applied to the validation set using Test-Time Dropout to generate 100 predictions for each instance. In each forward pass, the dropout probability of each neuron in each layer was independent of other passes (step 2). The predicted value for each instance in the validation set, #, was then calculated as the average across the 100 forward passes, and the standard deviation across passes, , was used as a measurement of the prediction's uncertainty 58 . Next (step 3), the residuals and the standard deviation across forward passes were used to generate a list of non-conformity values for the validation set as follows:
where 0 is the i th instance in the validation set, and 4 5 and 0 are the average and the standard deviation of the predicted activities for the i th instance across the 100 forward passes, respectively. The resulting list of non-conformity scores, , was sorted in increasing order, and the percentile corresponding to the Confidence Level considered was selected, e.g., :; for the 80 th percentile.
The residuals were normalized using the natural exponential of the standard deviation across the 100 forward passes because comparative analysis of non-conformity metrics (as shown in Equation 1) revealed that the exponential scaling improves the efficiency of Conformal
Predictors built on bioactivity data sets 39 . This scaling sets the upper value for the list of nonconformity values to be equal to the largest residual in the validation set, as the exponential converts low 0 values to values close to unity.
Finally, the standard deviation across forward passes was used to calculate confidence regions for the data points in the test set as follows (step 4 in Figure 1 ):
Where I is the j th instance in the test set, F 5 and I are the average and the standard deviation of the predicted activities for the j th instance across 100 forward passes, respectively.
Throughout this work we considered a Confidence Level of 80% unless otherwise stated, as this confidence level in our experience represents a generally suitable trade-off between efficiency and validity 39 .
-Random Forests
Cross-Conformal Predictors generated using Random Forests were used as a baseline for comparison. RF-based Cross-Conformal Predictors were generated as previously reported 34, 59 .
Briefly, RF models were trained on the training data using 10-fold cross validation. The crossvalidation residuals and the standard deviation across the Forest were used to calculate the list of non-conformity values for the training data 39, 57 , which were in turn used to compute confidence intervals for the test set instances.
Results and Discussion
We firstly compared the performance on the test set of DNN, using dropout probabilities in all layers of either 0.1, 0.25 or 0.5, and RF models (Figure 2) . Overall, the performance of RF and DNN (as well as performance for different dropout probabilities) was comparable, with RMSE values on the test set in the 0.55-0.80 pIC50 units range, indicating that our choice of DNN architectures and model parameters were suitable to model these data sets. Moreover, the RMSE values on the test set are consistent with the expected errors in prediction for machine learning models trained on heterogeneous IC50 data sets extracted from ChEMBL 60, 61 , and are in line with models reported in the literature for similar data sets 38 . Hence, the models obtained here are likely approaching the upper performance limit which can be obtained for the datasets used, which is also a likely factor behind the very similar performance obtained across methods.
In the Conformal Prediction literature, two main metrics are used to assess the practical usefulness of Conformal Predictors, namely validity and efficiency 29 . A Conformal Predictor is considered to be valid (or well calibrated) if the confidence level matches the fraction of data points in the test set whose true value lies within the predicted confidence region. For instance, at a confidence level of 80%, the confidence intervals computed using a valid Conformal
Predictor would contain the true value in at least 80% of the cases. The Conformal Predictors we generated using Test-Time Dropout are well calibrated (i.e., valid) for all dropout levels as well as for the RF-based models, as evidenced by the high correlation between the error rates and the confidence level (R 2 > 0.99, P < 0.001; Supplementary Figure 1 ).
Next, we evaluated the efficiency of the Conformal Predictors. The efficiency of a Conformal
Predictor is determined by the size of the confidence regions. While a Conformal Predictor might be valid, it might not be useful in practice if the confidence regions span several pIC50 units 39, 62 . The average size of the confidence regions computed using RF-based and Dropout
Conformal Predictors is comparable ( Figure 3) . However, the confidence intervals generated Predictors because, on average, the larger the variance across the ensemble, the larger the predicted confidence region will be (Equation 2).
In the case of DNN, variational inference applied to Test-Time Dropout ensembles has been shown to generate well-calibrated confidence intervals, as their size strongly correlated with the average error in prediction 24 . In the current study we find that the bagged variance computed using Test-Time Dropout DNN ensembles spans a narrower range of values than the bagged variance calculated using RF (Figure 4 and Supplementary Figure 2) , as evidenced by the larger spread of standard deviations between models (along the x-axis of Figure 4) . A constant trend across data sets is that the higher the dropout probability, the higher the spread of standard deviations across models ( Figure 4 and Supplementary Figure 2) . Although Dropout Conformal Predictors generated using forward passes are valid, the smaller spread of variance values indicates that the size of the confidence intervals computed for test molecules with different absolute errors in prediction will be comparable. In other words, we observe a weaker correlation between the bagged variance and the absolute error in prediction for dropout DNN as compared to RF models. Hence, this indicates that the size of the predicted confidence intervals from dropout DNN models are less representative of the absolute error in prediction than those computed from RF models.
A major practical application of predicting uncertainty in a drug discovery setting is the prioritization of compounds for further experimental testing by selecting those with the lower bound of the predicted confidence region over a given bioactivity cut-off value 29 . For instance, if the goal was to find molecules with a potency better than 10nM (pIC50>7), we would consider for further testing those molecules with a predicted confidence region that spans at least that value.
Therefore, we next sought to investigate the practical usefulness of RF-based and Dropout
Conformal Predictors to guide prospective virtual screening campaigns. To this aim, we defined as true positives (i.e., the molecules we are interested in selecting) those molecules with the predicted lower bound of the confidence interval (i.e., the lower end of the interval) above a given cut-off value (note that in real-world virtual screens also factors such as scaffold diversity etc.. are of relevance 67 , which have not been considered in further detail in this analysis). Figure   5 shows the distribution of (i) uncertain predictions: molecules for which the confidence region spans the cut-off value, (ii) false positives: molecules whose true pIC50 value is below the cut-off but the lower bound of the confidence region higher than the cut-off , (iii) true positives:
molecules for which the lower bound of the confidence region and the true pIC50 value are both over the cut-off (these are the molecules we would primarily prioritize for further experimental testing), and (iv) false negatives: molecules for which the upper bound of the confidence region is below the cut-off value but the true pIC50 value is over the cut-off. We considered 5 integervalued pIC50 cut-off values in the analysis, ranging from 5 to 9.
Overall, both the total number and fraction of true positives that are discovered are comparable across algorithms, suggesting that Dropout Conformal Predictors permit the discovery of compounds with an activity value over a certain pIC50 cut-off with comparable efficiency to RF ones, a trend that is observed across the pIC50 cut-off values considered. A similar trend is observed for the number of false positives, false negatives and molecules whose predicted confidence region spans the cut-off value of interest. Together, these results indicate that a comparable number of molecules with a potency over a cut-off value of interest would have been discovered by application of RF and Dropout Conformal Predictors.
Conclusions
In figure) consists of training a DNN using dropout. Subsequently, the network is applied to the validation set in 100 forward passes using random dropout (step 2). The residuals and variance across these 100 passes serve to compute a list of nonconformity scores (Equation 1). Next, the network is applied to the test set (step 3) 100 times using dropout as well. The resulting variance across forward passes is used to compute the point prediction and the confidence region (step 4 and Equation 2).
Figure 2 Assessment of the predictive power on the test set.
Mean RMSE values (+/-standard deviation) for the test set molecules averaged across 20 runs are shown. The modelling approaches considered (RF and DNN trained using increasingly larger dropout probabilities) showed high predictive power, with mean RMSE values in agreement with the uncertainty of heterogeneous data sets extracted from ChEMBL. The comparable performance of the models suggests that they are likely approaching the upper performance limit which can be obtained for the datasets used. . Overall, the base learners (i.e., trees) in the case of RF models display a larger variation than DNN ensembles generated using Test-Time Dropout, as evidenced by the larger spread on the x-axis. Overall, the smaller spread of variance values in the case of DNN indicates that the size of the confidence intervals computed for molecules with different absolute errors in prediction will be more similar than those computed with RF-based Conformal Predictors.
Figure 5 Comparison of retrieval rates for RF and Dropout Conformal Predictors.
Each column corresponds to a bioactivity cut-off value (pIC50>5, 6, 7, 8, or 9). The bars represent the total number of test instances for which: (i) the confidence region spans the cut-off value (i.e., uncertain predictions; shown in turquoise), (ii) the lower bound of the confidence region is higher than the cut-off value but the observed pIC50 value is below the cut-off (i.e., false positives, shown in yellow), (iii) the lower bound of the confidence region is higher than the cut-off value and the observed pIC50 value is over the cut-off (i.e., true positives; shown in purple), and (iv) the upper bound of the confidence region is below the cut-off value but the observed pIC50 value is over the cut-off (i.e., false negatives; shown in red). The numbers on top of the bars indicate the percentage of true positives (i.e., molecules for which both the lower end of the confidence interval and the true pIC50 value are above the cut-off). The average values across the 20 runs are shown. Overall, both the total number and fraction of true positives that are discovered are comparable across algorithms, suggesting that DNN Dropout Conformal Predictors permit the discovery of compounds with an activity value over a certain pIC50 cut-off with comparable efficiency to RF ones while avoiding models with excessive prediction uncertainty.
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